U.S. Markets open in 3 hrs 14 mins

A Look into Johnson & Johnson’s Diabetes Care Business

Daniel Collins
A Look into Johnson & Johnson’s Diabetes Care Business

Johnson & Johnson’s (JNJ) Diabetes Care segment generated revenues of $319.0 million in the third quarter, reflecting an ~22.2% YoY (year-over-year) decline and an 11.0% decline sequentially. Johnson & Johnson’s Diabetes Care segment reported an ~20.0% YoY operational decline in the third quarter.